Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Impel Pharmaceuticals logo

Impel Pharmaceuticals

Recent Finacing

Debt

Recent Raise

$50M

Impel NeuroPharma is a clinical-stage biopharma developing intranasal drug-device combination products using its Precision Olfactory Delivery (POD) platform to target CNS disorders including migraine, Parkinson’s, and Alzheimer’s.

Founded 2008
Washington, United States
51-100
Publicly Traded
impelnp.com

Highlights

Focus Areas

Biotechnology
Delivery
Health Care
Medical
Medical Device
Pharmaceutical

Recent Investors

Vivo Capital logo
venBio Partners logo
5AM Ventures logo
Norwest Venture Partners logo
KKR logo
Silicon Valley Bank logo
Oxford Finance logo
3M Ventures logo

Financials

$165.5M

Total Raised

4

Funding rounds

8

Investors


Team

Upgrade to view the team

See the team members at Impel Pharmaceuticals.